These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28274274)

  • 1. A novel form of necrosis, TRIAD, occurs in human Huntington's disease.
    Yamanishi E; Hasegawa K; Fujita K; Ichinose S; Yagishita S; Murata M; Tagawa K; Akashi T; Eishi Y; Okazawa H
    Acta Neuropathol Commun; 2017 Mar; 5(1):19. PubMed ID: 28274274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting TEAD/YAP-transcription-dependent necrosis, TRIAD, ameliorates Huntington's disease pathology.
    Mao Y; Chen X; Xu M; Fujita K; Motoki K; Sasabe T; Homma H; Murata M; Tagawa K; Tamura T; Kaye J; Finkbeiner S; Blandino G; Sudol M; Okazawa H
    Hum Mol Genet; 2016 Nov; 25(21):4749-4770. PubMed ID: 28171658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hippo Signaling Pathway Dysregulation in Human Huntington's Disease Brain and Neuronal Stem Cells.
    Mueller KA; Glajch KE; Huizenga MN; Wilson RA; Granucci EJ; Dios AM; Tousley AR; Iuliano M; Weisman E; LaQuaglia MJ; DiFiglia M; Kegel-Gleason K; Vakili K; Sadri-Vakili G
    Sci Rep; 2018 Jul; 8(1):11355. PubMed ID: 30054496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional repression induces a slowly progressive atypical neuronal death associated with changes of YAP isoforms and p73.
    Hoshino M; Qi ML; Yoshimura N; Miyashita T; Tagawa K; Wada Y; Enokido Y; Marubuchi S; Harjes P; Arai N; Oyanagi K; Blandino G; Sudol M; Rich T; Kanazawa I; Wanker EE; Saitoe M; Okazawa H
    J Cell Biol; 2006 Feb; 172(4):589-604. PubMed ID: 16461361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of apoptosis signal-regulating kinase 1 reduces endoplasmic reticulum stress and nuclear huntingtin fragments in a mouse model of Huntington disease.
    Cho KJ; Lee BI; Cheon SY; Kim HW; Kim HJ; Kim GW
    Neuroscience; 2009 Nov; 163(4):1128-34. PubMed ID: 19646509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein changes in synaptosomes of Huntington's disease knock-in mice are dependent on age and brain region.
    Sapp E; Seeley C; Iuliano M; Weisman E; Vodicka P; DiFiglia M; Kegel-Gleason KB
    Neurobiol Dis; 2020 Jul; 141():104950. PubMed ID: 32439598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease.
    Hermel E; Gafni J; Propp SS; Leavitt BR; Wellington CL; Young JE; Hackam AS; Logvinova AV; Peel AL; Chen SF; Hook V; Singaraja R; Krajewski S; Goldsmith PC; Ellerby HM; Hayden MR; Bredesen DE; Ellerby LM
    Cell Death Differ; 2004 Apr; 11(4):424-38. PubMed ID: 14713958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.
    Louis Sam Titus ASC; Yusuff T; Cassar M; Thomas E; Kretzschmar D; D'Mello SR
    J Neurosci; 2017 Jul; 37(27):6575-6587. PubMed ID: 28550168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YAP-dependent necrosis occurs in early stages of Alzheimer's disease and regulates mouse model pathology.
    Tanaka H; Homma H; Fujita K; Kondo K; Yamada S; Jin X; Waragai M; Ohtomo G; Iwata A; Tagawa K; Atsuta N; Katsuno M; Tomita N; Furukawa K; Saito Y; Saito T; Ichise A; Shibata S; Arai H; Saido T; Sudol M; Muramatsu SI; Okano H; Mufson EJ; Sobue G; Murayama S; Okazawa H
    Nat Commun; 2020 Jan; 11(1):507. PubMed ID: 31980612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease.
    Wellington CL; Ellerby LM; Gutekunst CA; Rogers D; Warby S; Graham RK; Loubser O; van Raamsdonk J; Singaraja R; Yang YZ; Gafni J; Bredesen D; Hersch SM; Leavitt BR; Roy S; Nicholson DW; Hayden MR
    J Neurosci; 2002 Sep; 22(18):7862-72. PubMed ID: 12223539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMPK-α1 functions downstream of oxidative stress to mediate neuronal atrophy in Huntington's disease.
    Ju TC; Chen HM; Chen YC; Chang CP; Chang C; Chern Y
    Biochim Biophys Acta; 2014 Sep; 1842(9):1668-80. PubMed ID: 24946181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIPK3 modulates autophagy and HTT protein levels in neuronal and mouse models of Huntington disease.
    Fu Y; Sun X; Lu B
    Autophagy; 2018; 14(1):169-170. PubMed ID: 29130397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD).
    Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA
    Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass Spectrometry Analysis of Wild-Type and Knock-in Q140/Q140 Huntington's Disease Mouse Brains Reveals Changes in Glycerophospholipids Including Alterations in Phosphatidic Acid and Lyso-Phosphatidic Acid.
    Vodicka P; Mo S; Tousley A; Green KM; Sapp E; Iuliano M; Sadri-Vakili G; Shaffer SA; Aronin N; DiFiglia M; Kegel-Gleason KB
    J Huntingtons Dis; 2015; 4(2):187-201. PubMed ID: 26397899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Exogenous NUB1 Expression in the Striatum of HDQ175/Q7 Mice.
    Vodicka P; Chase K; Iuliano M; Valentine DT; Sapp E; Lu B; Kegel-Gleason KB; Sena-Esteves M; Aronin N; DiFiglia M
    J Huntingtons Dis; 2016 Jun; 5(2):163-74. PubMed ID: 27314618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rrs1 is involved in endoplasmic reticulum stress response in Huntington disease.
    Carnemolla A; Fossale E; Agostoni E; Michelazzi S; Calligaris R; De Maso L; Del Sal G; MacDonald ME; Persichetti F
    J Biol Chem; 2009 Jul; 284(27):18167-73. PubMed ID: 19433866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.
    Wegrzynowicz M; Bichell TJ; Soares BD; Loth MK; McGlothan JS; Mori S; Alikhan FS; Hua K; Coughlin JM; Holt HK; Jetter CS; Pomper MG; Osmand AP; Guilarte TR; Bowman AB
    J Huntingtons Dis; 2015; 4(1):17-36. PubMed ID: 26333255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omi / HtrA2 is relevant to the selective vulnerability of striatal neurons in Huntington's disease.
    Inagaki R; Tagawa K; Qi ML; Enokido Y; Ito H; Tamura T; Shimizu S; Oyanagi K; Arai N; Kanazawa I; Wanker EE; Okazawa H
    Eur J Neurosci; 2008 Jul; 28(1):30-40. PubMed ID: 18662332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental YAPdeltaC determines adult pathology in a model of spinocerebellar ataxia type 1.
    Fujita K; Mao Y; Uchida S; Chen X; Shiwaku H; Tamura T; Ito H; Watase K; Homma H; Tagawa K; Sudol M; Okazawa H
    Nat Commun; 2017 Nov; 8(1):1864. PubMed ID: 29192206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease.
    Ma Q; Yang J; Li T; Milner TA; Hempstead BL
    Neurobiol Dis; 2015 Oct; 82():466-477. PubMed ID: 26282324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.